Kpax is there some sort of guide as to the success rates of an in vitro test when transferred to human tests?
Most seem to fail to replicate petri tests and I'm sure it could be for a 1000 reasons. I guess im trying to understand if there are any obvious mechanisms that could stop the drug being as effective when swallowed by a human vs applied in a Petri dish.
Would it be somewhat safe (not foolproof) to assume that since we saw real mtor effects in live specimens (canines), albeit targeting a complete different illness, that we know the drug is absorbed etc and so would likely be useful in humans for covid?
I'm trying to understand how realistic it is for the same effect (95%) to be replicated in human trials.
Ann: Confirmation of Preliminary COVID-19 Results, page-159
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.42M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.3¢ | 19.0¢ | $25.41K | 133.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5372 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 262575 | 3 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |